Analyses of clinical data-linked, genome-wide databases have identified interactions between PIK3CA and YAP activation in HNSCC and demonstrated that these interactions may be associated with survival outcomes. The gene discussed is YAP1; the disease is head and neck squamous cell carcinoma.